logo
Marco Bizzarri Gives Address With Advice for Fashion's Next Generation

Marco Bizzarri Gives Address With Advice for Fashion's Next Generation

At a ceremony in London's Royal Festival Hall last Thursday, Marco Bizzarri, the former Gucci chief executive who led the brand during its dramatic growth under creative director Alessandro Michele, offered his words of advice to students entering the fashion industry.
'You're going to face a lot of hurdles,' he said. 'But I really wish you to find in your journey people that are going to love you, that are going to support you, that are going to mentor you, that are going to believe in you, like they believed in me, more than I believed in myself in certain moments. Because nobody — nobody — is born to be a CEO, or creative director.'
Bizzarri gave his address while accepting an honorary degree from the University for the Creative Arts for his vast contributions to the fashion industry. In his more than 30 years in fashion, he served as president and CEO at Stella McCartney and Bottega Veneta before his appointment in 2015 to the top job at Gucci, where he led a historically successful turnaround during his eight-year tenure. One of his first strategic decisions in the role was to name as creative director the relatively unknown Michele, who rebranded the Italian fashion house in his campy, idiosyncratic aesthetic. Between 2015 and 2019, sales more than doubled while profits quadrupled before growth slowed. Bizzarri exited Gucci in 2023.
His guidance comes during a critical moment for fashion newcomers, who face a turbulent industry that has seen challenges to diversity and sustainability, tariff-induced chaos and a steep downturn in luxury spending. In his speech, he recounted his feelings as someone from a small village in Italy arriving in London to take over as CEO of Stella McCartney in 2005. 'It was like the dream of my life,' he said, but admitted that it was also scary for him. What helped him were the people he was surrounded by.
He would go on to manage larger and larger companies with different cultures and complexities. While Bizzarri said there was no single formula for success, at the start of any new endeavour he would start by asking himself why and how he wanted to do it.
'The second most important thing is to find who you want to work with, the talents that you want to be with you, that they support you and ideally that are better than you, because if they are better than you, you can start to do other things,' he said. 'Never be scared of talents.'
The advice was fitting from Bizzarri, who was known for boosting workplace morale by increasing company transparency, including to retail employees, and who is largely credited with transforming Gucci's brand culture from one based in fear to one of mutual respect.
Since departing Gucci, Bizzarri has invested in fashion and design through his family holding company, Nessifashion, and co-founded private-equity firm Forel, which acquired a majority stake in Italian luxury interior design brand Visionnaire as its first venture in April 2024. That same month, Bizzarri acquired a 23 percent stake in Italian fashion label Elisabetta Franchi, of which he now serves as chairman. Last September, Bizzarri also became an informal advisor to Margherita Missoni's womenswear line Maccapani after his family made a minority investment in the brand in his daughter Federica's name.
Bizzarri joins the ranks of previous UCA honourees including Naomi Campbell, Moncler CEO and chairman Remo Ruffini and Jonathan Anderson, who accepted the distinction last year.
Learn more:
As Gucci's CEO Steps Down, Saint Laurent's Chief Steps Up
Marco Bizzarri led the Italian luxury giant through a historic expansion before the business struggled to bounce back from the pandemic. Parent company Kering announced the move as part of a broader executive shakeup after which Saint Laurent CEO Francesca Bellettini will oversee all the group's brands.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.

Business Wire

time22 minutes ago

  • Business Wire

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company's ongoing capital expenditure projects in Cisterna di Latina (Italy) and Fishers (Indiana, U.S.). The financing agreements bolster Stevanato Group's capacity expansion efforts and the scaling of commercial production to support customers' growing biologics programs. CDP has committed €50 million to enhance the production of pre-filled syringes and set-up future capacity for ready-to-use (RTU) cartridges at Stevanato Group's Italian plant in Cisterna di Latina. Additionally, BNL BNP Paribas has provided €100 million, and Banco BPM has contributed €50 million, both aimed at scaling pre-filled syringe production at the company's facilities in North America (Indiana) and Italy, as well as completing the ongoing construction for device manufacturing in Fishers. 'These agreements are an important element to Stevanato Group's financial strategy, allowing us to capitalize on robust customer demand and support the Company's long-term growth objectives,' stated Marco Dal Lago, Chief Financial Officer of Stevanato Group. 'We are committed to supporting our customers' biopharmaceutical programs with our unique value proposition of offering integrated solutions across the pharmaceutical value chain, helping to enable our customers to meet and exceed their program objectives.' BNL BNP Paribas and Cassa Depositi e Prestiti have renewed their support for Stevanato Group to achieve long-term organic growth objectives in its key end-markets. Gianluca Mariani, Head of Industrial Manufacturing, Large Corporate Banking at BNL BNP Paribas: 'Our support for Stevanato Group reflects our commitment to partnering with companies that invest in innovation, sustainability and global expansion. Stevanato Group is a leading example of excellence in its sector, and our goal is to make our domestic and international platforms available to contribute to the growing ambitions of the Company in the coming years.' 'We are proud to once again support the growth plans of Stevanato Group, a leading Italian company active in the pharmaceutical sector, which is strategic for the Country,' stated Marco Roberto Pessione, Head of Corporate Coverage at CDP. 'We firmly believe in the value of companies that invest in research, quality, and sustainable development, and that make a tangible contribution to the growth of the national economy. We remain committed to standing alongside these businesses, providing effective financial instruments to support their growth and consolidation plans both in Italy and internationally.' 'We are proud to support a company like Stevanato Group, a symbol of Italian industrial excellence worldwide, in its solid and innovation-driven growth journey,' said Enrico Lemmo, Head of Corporate Banking North-East at Banco BPM. 'This financing reflects our commitment to backing projects that create value locally while strengthening the international competitiveness of Italian enterprises.' Forward-Looking Statements This press release may include forward-looking statements. The words 'growing,' 'enhancing,' 'intended,' 'are seeing,' 'are committed,' 'achieve,' 'enable,' and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding the Company's intentions, beliefs or current expectations concerning, among other things, the investments the Company expects to receive, the expansion of manufacturing capacity, the Company's plans regarding its presence in the U.S. market, business strategies, the Company's capacity to meet future market demands and support preparedness for future public health emergencies, and results of operations. The forward-looking statements in this press release are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond the Company's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of regulators and other factors such as the Company's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. Except as required by law, the company assumes no obligation to update any such forward-looking statements. About Stevanato Group Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. To learn more, visit: BNL BNP Paribas With more than one hundred years' experience, BNL BNP Paribas is one of the main Italian banking groups and one of the most well-known brands in Italy, where it operates all over the Country. It offers a wide range of products and services to meet the diverse needs of its clients (individuals, businesses, and public administrations). Since 2006, BNL has been part of BNP Paribas, a Group present in 63 countries with approximately 183,000 employees, including over 146,000 in Europe, where it operates in four domestic markets: Belgium, France, Italy, and Luxembourg. BNP Paribas holds key positions in its major business segments: Commercial, Personal Banking & Services; Investment & Protection Services; and Corporate & Institutional Banking. Like the entire Group, BNL BNP Paribas is particularly committed to economic, social, and environmental sustainability; a strategy that epitomizes the Bank's ambition to generate, through its business, a positive impact on clients, employees, and the community, contributing to a more sustainable future. About CDP Cassa Depositi e Prestiti is the National Promotional Institute which has been supporting the Italian economy since 1850. The main goal of CDP is to accelerate the industrial and infrastructural development of Italy to boost its economic and social growth. CDP focuses its activities on sustainable development at local level, supporting the innovation and growth of Italian enterprises, also in the international arena. It partners local authorities, in a financing and advisory capacity, to create infrastructures and improve services of public value. CDP also participates actively in international cooperation initiatives to realize projects in developing countries and emerging markets. Cassa Depositi e Prestiti is entirely financed by private capital, through the issuing of Postal Savings Bonds and Postal Savings Passbooks, and through issues on national and international financial markets. About Banco BPM On 1 January 2017, two large so-called 'popolari' banks, Banco Popolare and Banca Popolare di Milano, merged and transformed into a joint stock company (S.p.A.). The Banco BPM Group was established: a solid entity, with over 20,000 employees, 1,400 branches and around 4 million customers. Banco BPM, which today is Italy's third largest financial services group in terms of assets, has a deeply rooted presence in the regions of Northern Italy, including those with the highest industrial concentration in Europe. A widespread network serving households and businesses, an in-depth knowledge of the markets and innovative solutions underpin the strength of Banco BPM, which is active in various areas of the banking sector – private and investment banking, asset management, bancassurance – also through the Group's subsidiaries. Banco BPM's business model focuses on its people and their skills, enhanced by constant training. The Group operates in the tradition of 'popolari' banks, generating profitability for its shareholders and creating value for all its stakeholders in the areas in which it is present, so as to play a leading role in the sustainable and inclusive development of the country.

Luxury heavyweights struggle to shake off shopper fatigue
Luxury heavyweights struggle to shake off shopper fatigue

Yahoo

time4 hours ago

  • Yahoo

Luxury heavyweights struggle to shake off shopper fatigue

By Mimosa Spencer PARIS (Reuters) -LVMH and Kering are expected to report another drop in quarterly sales, deepening investor worries about a prolonged downturn in the $400 billion luxury market as brands face the threat of hefty U.S. import tariffs. The results, kicking off with LVMH on Thursday, will likely show that any revival in demand for pricey fashion in the key U.S. and Chinese markets remains elusive. Uncertainty unleashed by U.S. President Donald Trump's trade war has caused volatility in stock markets, weighing on consumer confidence. Trump's threat of 30% tariffs on imported EU goods risks hurting luxury houses that make products in France and Italy. They will be wary of lifting prices for U.S. consumers after signs that previous rounds of price hikes slowed demand. "The level of price increases has been too much" at a number of brands, alienating the "aspirational" middle-income shoppers, said Caroline Reyl, head of premium brands at Pictet Asset Management. LVMH's fashion and leather goods division, home to Louis Vuitton and Dior, is expected to show sales down 6% year-on-year, its fourth consecutive quarterly decline, according to a Visible Alpha consensus forecast. Gucci, Kering's main earner which is undergoing an overhaul, has struggled for twice as long and is seen reporting sales down nearly a quarter from a year earlier. After two years of slowing sales, unease about the health of the industry is growing, with customers balking at higher price tags. Shares of LVMH are down nearly 27% since the start of this year, while shares of Kering are down 15%. Shares of Hermes and Richemont, which cater to mostly wealthy clients, were little changed, with the former down 0.9% and the latter up 1.6% over the same period. LVMH, Europe's most valuable listed company as recently as January, has slipped to fifth place. "It seems that investors are starting to worry about the long-term structural attractiveness of the industry," UBS analysts said last week. Sales of handbags - previously a growth engine - have been weak as shoppers opt for timeless, investment-grade jewellery. Brands including Dior, Gucci and Chanel have recruited new designers, but it takes time for fresh styles to enter stores. LOWER-PRICED PRODUCTS Brands like Louis Vuitton and Prada are offering more products below $1,000, like a new hybrid ballerina-sneaker shoe, for example, and emphasising beauty products, said Bain consultants. But that carries risks. "The aspirational skew of the brand is unhelpful currently," said HSBC analysts, highlighting problems at Louis Vuitton. "Some inconsistencies, we feel, are likely starting to have consumers wonder." Consensus forecasts peg organic sales of LVMH down 3%, while Kering is seen down 13%; Hermes and Prada are expected to show a 10% rise, as Prada's Miu Miu label takes market share from rivals. Kering will report its results on July 29, while Hermes and Prada are due to report on July 30.

Luxury heavyweights struggle to shake off shopper fatigue
Luxury heavyweights struggle to shake off shopper fatigue

Yahoo

time4 hours ago

  • Yahoo

Luxury heavyweights struggle to shake off shopper fatigue

By Mimosa Spencer PARIS (Reuters) -LVMH and Kering are expected to report another drop in quarterly sales, deepening investor worries about a prolonged downturn in the $400 billion luxury market as brands face the threat of hefty U.S. import tariffs. The results, kicking off with LVMH on Thursday, will likely show that any revival in demand for pricey fashion in the key U.S. and Chinese markets remains elusive. Uncertainty unleashed by U.S. President Donald Trump's trade war has caused volatility in stock markets, weighing on consumer confidence. Trump's threat of 30% tariffs on imported EU goods risks hurting luxury houses that make products in France and Italy. They will be wary of lifting prices for U.S. consumers after signs that previous rounds of price hikes slowed demand. "The level of price increases has been too much" at a number of brands, alienating the "aspirational" middle-income shoppers, said Caroline Reyl, head of premium brands at Pictet Asset Management. LVMH's fashion and leather goods division, home to Louis Vuitton and Dior, is expected to show sales down 6% year-on-year, its fourth consecutive quarterly decline, according to a Visible Alpha consensus forecast. Gucci, Kering's main earner which is undergoing an overhaul, has struggled for twice as long and is seen reporting sales down nearly a quarter from a year earlier. After two years of slowing sales, unease about the health of the industry is growing, with customers balking at higher price tags. Shares of LVMH are down nearly 27% since the start of this year, while shares of Kering are down 15%. Shares of Hermes and Richemont, which cater to mostly wealthy clients, were little changed, with the former down 0.9% and the latter up 1.6% over the same period. LVMH, Europe's most valuable listed company as recently as January, has slipped to fifth place. "It seems that investors are starting to worry about the long-term structural attractiveness of the industry," UBS analysts said last week. Sales of handbags - previously a growth engine - have been weak as shoppers opt for timeless, investment-grade jewellery. Brands including Dior, Gucci and Chanel have recruited new designers, but it takes time for fresh styles to enter stores. LOWER-PRICED PRODUCTS Brands like Louis Vuitton and Prada are offering more products below $1,000, like a new hybrid ballerina-sneaker shoe, for example, and emphasising beauty products, said Bain consultants. But that carries risks. "The aspirational skew of the brand is unhelpful currently," said HSBC analysts, highlighting problems at Louis Vuitton. "Some inconsistencies, we feel, are likely starting to have consumers wonder." Consensus forecasts peg organic sales of LVMH down 3%, while Kering is seen down 13%; Hermes and Prada are expected to show a 10% rise, as Prada's Miu Miu label takes market share from rivals. Kering will report its results on July 29, while Hermes and Prada are due to report on July 30.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store